Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 27, 2023 Filed Nov 29, 2023 21:08 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000244 · wk-form4_1701292109.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionRestricted Stock Unit · Derivative 805 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · derivative · entry 7

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,835

Underlying: Common Stock · 805 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionRestricted Stock Unit · Derivative 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · derivative · entry 6

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,005

Underlying: Common Stock · 168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
Tax withholdingCommon Stock 333 $18.20 $6,060.60
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · nonDerivative · entry 5

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,932

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionCommon Stock 805 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · nonDerivative · entry 4

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
Tax withholdingCommon Stock 70 $18.20 $1,274.00
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · nonDerivative · entry 3

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,460

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionCommon Stock 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,530

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 16:11 UTC
Leal JamesChief Manufacturing Officer
GrantCommon Stock 16 $15.47 $247.52
Disclosure

SEC source: 0001438133-23-000231 · wk-form4_1700255469.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,362

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · derivative · entry 7

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · derivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 164 $18.20 $2,984.80
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,561

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 57 $18.20 $1,037.40
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,251

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
GrantCommon Stock 565 $15.47 $8,740.55
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,146

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · derivative · entry 8

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F8 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F8 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · derivative · entry 7

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 164 $18.20 $2,984.80
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 5

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,034

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 57 $18.20 $1,037.40
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 3

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,724

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,781

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
GrantCommon Stock 1 $15.47 $15.47
Disclosure

SEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,619

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000233 · wk-form4_1700255505.xml · derivative · entry 6

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000233 · wk-form4_1700255505.xml · derivative · entry 5

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 135 $18.20 $2,457.00
Disclosure

SEC source: 0001438133-23-000233 · wk-form4_1700255505.xml · nonDerivative · entry 4

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,447

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000233 · wk-form4_1700255505.xml · nonDerivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 47 $18.20 $855.40
Disclosure

SEC source: 0001438133-23-000233 · wk-form4_1700255505.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,108

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000233 · wk-form4_1700255505.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 2,236 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · derivative · entry 7

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,418

Underlying: Common Stock · 2,236 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 792 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · derivative · entry 6

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,755

Underlying: Common Stock · 792 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 774 $18.20 $14,086.80
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · nonDerivative · entry 5

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,039

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 2,236 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · nonDerivative · entry 4

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 274 $18.20 $4,986.80
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · nonDerivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,577

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 792 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
Sheridan John FDirector · PRESIDENT & CEO
GrantCommon Stock 98 $15.47 $1,516.06
Disclosure

SEC source: 0001438133-23-000232 · wk-form4_1700255487.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,059

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · derivative · entry 7

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · derivative · entry 6

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 157 $18.20 $2,857.40
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · nonDerivative · entry 5

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,351

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · nonDerivative · entry 4

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 54 $18.20 $982.80
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · nonDerivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,034

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,088

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:11 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
GrantCommon Stock 1 $15.47 $15.47
Disclosure

SEC source: 0001438133-23-000230 · wk-form4_1700255433.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,926

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Hansen Shannon MarieChief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 530 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000229 · wk-form4_1700255415.xml · derivative · entry 4

Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,777

Underlying: Common Stock · 530 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Hansen Shannon MarieChief Legal Officer
Tax withholdingCommon Stock 184 $18.20 $3,348.80
Disclosure

SEC source: 0001438133-23-000229 · wk-form4_1700255415.xml · nonDerivative · entry 2

Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,263

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:10 UTC
Hansen Shannon MarieChief Legal Officer
Exercise / conversionCommon Stock 530 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000229 · wk-form4_1700255415.xml · nonDerivative · entry 1

Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Carpenter RickChief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 596 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000225 · wk-form4_1700255351.xml · derivative · entry 4

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,574

Underlying: Common Stock · 596 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Carpenter RickChief Technology Officer
Tax withholdingCommon Stock 207 $18.20 $3,767.40
Disclosure

SEC source: 0001438133-23-000225 · wk-form4_1700255351.xml · nonDerivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,224

F2 · shares: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Carpenter RickChief Technology Officer
Exercise / conversionCommon Stock 596 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000225 · wk-form4_1700255351.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
Carpenter RickChief Technology Officer
GrantCommon Stock 241 $15.47 $3,728.27
Disclosure

SEC source: 0001438133-23-000225 · wk-form4_1700255351.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,835

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.